Regional Xenon 133 Cerebral Blood Flow and Cerebral Technetium 99m HMPAO Uptake in Unmedicated Patients with Obsessive-Compulsive Disorder and Matched Normal Control Subjects: Determination by High-Resolution Single-Photon Emission Computed Tomography

Archives of General Psychiatry

Volumn 49, Issue 9, 1992, Pages 695-702

  Rubin, Robert T ^a,c   Villanueva Meyer, Javier ^a   Ananth, Jambur ^a   Trajmar, Peter G ^b   Mena, Ismael ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; XENON 133;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CORTEX; CAUDATE NUCLEUS; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG UPTAKE; HUMAN; HYDROPHILICITY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEMBRANE PERMEABILITY; OBSESSION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BASAL GANGLIA; BLOOD-BRAIN BARRIER; CAUDATE NUCLEUS; CELL MEMBRANE PERMEABILITY; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COMPARATIVE STUDY; HUMAN; LATERALITY; MALE; OBSESSIVE-COMPULSIVE DISORDER; ORGANOTECHNETIUM COMPOUNDS; OXIMES; PERMEABILITY; PUTAMEN; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TECHNETIUM TC 99M EXAMETAZIME; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; XENON RADIOISOTOPES;

EID: 0026757703     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1992.01820090023004     Document Type: Article

References (46)

1. Robins LM, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD Jr, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41: 949–958.
2. Myers JK, Weissman MM, Tischler GL, Holzer CE III, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke JD Jr, Kramer M, Stoltzman R. Six-month prevalence of psychiatric disorders in three communities. Arch Gen Psychiatry. 1984;41: 959–967.
3. Murphy DL, Pato MT, Pigott TA. Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents. J Clin Psychopharmacol. 1990;10: 91S–100S.
4. Malloy P, Rasmussen S, Braden W, Haier RJ. Topographic evoked potential mapping in obsessive-compulsive disorder: evidence of frontal lobe dysfunction. Psychiatry Res. 1989;28: 63–71.
5. Hollander E, Schiffman E, Cohen B, Rivera-Stein MA, Rosen W, Gorman JM, Fyer AJ, Papp L, Liebowitz MR. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch Gen Psychiatry. 1990;47: 27–32.
6. Bihari K, Pato MT, Hill JL, Murphy DL. Neurologic soft signs in obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48:278.
7. Lieberman J. Evidence for a biological hypothesis of obsessive-compulsive disorder. Neuropsychobiology. 1884;11: 14–21.
8. Jenike MA. Obsessive-compulsive disorder: a question of a neurologic lesion. Compr Psychiatry. 1984;25: 298–304.
9. Insel TR. Obsessive-compulsive disorder. Psychiatr Clin North Am. 1985;8: 105–117.
10. Khanna S. Obsessive-compulsive disorder: is there a frontal lobe dysfunction? Biol Psychiatry. 1988;24: 602–613.
11. Wise SP, Rapoport JL. Obsessive-compulsive disorder: is it basal ganglia dysfunction? In: Rapoport JL, ed. Obsessive-Compulsive Disorder in Children and Adolescents. Washington, DC: American Psychiatric Press Inc; 1989: 327–344.
12. Rapoport JL. Obsessive-compulsive disorder and basal ganglia dysfunction. Psychol Med. 1990;20: 465–469.
13. Baxter LR. Brain imaging as a tool in establishing a theory of brain pathology in obsessive-compulsive disorder. J Clin Psychiatry. 1990;51(suppl): 22–25.
14. Insel TR, Donnelly EF, Lalakea ML, Alterman IS, Murphy DL. Neurological and neuropsychological studies of patients with obsessive-compulsive disorder. Biol Psychiatry. 1983;18: 741–751.
15. Behar D, Rapoport JL, Berg CJ, Denckla MB, Mann L, Cox C, Fedio P, Zahn T, Wolfman MG. Computerized tomography and neuropsychological test measures in adolescents with obsessive-compulsive disorder. Am J Psychiatry. 1984;141: 363–369.
16. Luxenberg JS, Swedo SE, Flament MF, Friedland RP, Rapoport J, Rapoport SI. Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative x-ray computed tomography. Am J Psychiatry. 1988;145: 1089–1093.
17. Garber HJ, Ananth JV, Chiu LC, Griswold VJ, Oldendorf WH. Nuclear magnetic resonance study of obsessive-compulsive disorder. Am J Psychiatry. 1989;146: 1001–1005.
18. Kellner CH, Jolley RR, Holgate RC, Austin L, Lydiard RB, Laraia M, Ballenger JC. Brain MRI in obsessive-compulsive disorder. Psychiatry Res. 1991;36: 45–49.
19. Bench CJ, Dolan RJ, Friston KJ, Frackowiak RSJ. Positron emission tomography in the study of brain metabolism in psychiatric and neuropsychiatric disorders. Br J Psychiatry. 1990;157(suppl 9): 82–95.
20. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987;44: 211–218.
21. Baxter LR Jr, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH, Fairbanks L. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry. 1988;145: 1560–1563.
22. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM. Cerebral glucose metabolic rates in obsessive-compulsive disorder. Neuropsychopharmacology. 1989;2: 23–28.
23. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport SI, Rapoport JL. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 1989;46: 518–523.
24. Martinot JL, Allilaire JF, Mazoyer BM, Hantouche E, Huret JD, Legaut-Demare F, Deslauriers AG, Hardy P, Pappata S, Baron JC, Syrota A. Obsessive-compulsive disorder: a clinical, neuropsychological and positron emission tomography study. Acta Psychiatr Scand. 1990;82: 233–242.
25. Lou HC, Edvinsson L, MacKenzie ET. The concept of coupling blood flow to brain function: revision required? Ann Neurol. 1987;22: 289–297.
26. Zohar J, Insel TR, Berman KF, Foa EB, Hill JL, Weinberger DR. Anxiety and cerebral blood flow during behavioral challenge: dissociation of central from peripheral and subjective measures. Arch Gen Psychiatry. 1989;46: 505–510.
27. Hollander E, DeCaria CM, Saoud JB, Trungold S, Stein DJ, Liebowitz MR, Prohovnik I. M-CPP—activated regional cerebral blood flow in obsessive-compulsive disorder. Biol Psychiatry. 1991;29:170A.
28. Machlin SR, Harris GJ, Pearlson GD, Hoehn-Saric R, Jeffery P, Camargo EE. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. Am J Psychiatry. 1991;148: 1240–1242.
29. Hoehn-Saric R, Pearlson GD, Harris GJ, Machlin SR, Camargo EE. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry. 1991;148: 1243–1245.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987: 245–247.
31. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R. New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1988 version.
32. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive-Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46: 1006–1011.
33. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive-Compulsive Scale, II: validity. Arch Gen Psychiatry. 1989;46: 1012–1016.
34. Kety SS. Theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev. 1951;3: 1–41.
35. Uemura K, Kanno I, Miura Y, Miura S, Tominaga S. Tomographic study of regional cerebral blood flow in ischemic cerebrovascular disease by Kr-81m intra-arterial infusion and HEADTOME. J Comput Assist Tomogr. 1982;6: 677–682.
36. Kanno I, Lassen NA. Two methods for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr. 1979;3: 71–76.
37. Celsis P, Goldman T, Henriksen L, Lassen NA. A method for calculating regional cerebral blood flow from emission computed tomography of inert gas concentration. J Comput Assist Tomogr. 1981;5: 641–645.
38. Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NTS, Gvozdanovic D, Davidson J, Tyrell DA, Pickett RD, Neirinckx RD. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med. 1986;27: 171–177.
39. Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volckert WA, Foster AM, Weisner PS, Marriott JA, Chaplin SB. Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med. 1987;28: 191–202.
40. Anderson AR, Friberg H, Knudsen KBM, Barry DI, Paulson OB, Schmidt JS, Lassen NA, Neirinckx RD. Extraction of [99mTc]-d,l-HMPAO across the blood-brain barrier. J Cereb Blood Flow Metab. 1988;8:S44-S51.
41. De Jong BM, Van Royen EA. Uptake of SPECT radiopharmaceuticals in neocortical brain cultures. EurJ Nucl Med. 1989;15: 16–20.
42. Pawlik G. Statistical analysis of functional neuroimaging data: exploratory versus inferential methods. J Cereb Blood Flow Metab. 1991;11:A136-A139.
43. Pupi A, De Cristofaro MTR, Bacciottini L, Antoniucci D, Formiconi AR, Mascalchi M, Meldolesi U. An analysis of the arterial input curve for technetium-99m-HMPAO: quantification of rCBF using single-photon emission computed tomography. J Nucl Med. 1991;32: 1501–1506.
44. Mazziotta JC, Phelps ME, Plummer D, Kuhl DE. Quantitation in positron emission computed tomography, 5: physical-anatomical effects. J Comput Assist Tomogr. 1981;5: 734–743.
45. Lassen NA, Andersen AR, Friberg L, paulson OB. The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab. 1988;8:S13-S22.
46. Baxter LR. PET studies of cerebral function in major depression and obsessive-compulsive disorder: the emerging prefrontal cortex consensus. Ann Clin Psychiatry. 1991;3: 103–109.